Kkr Phorm Investors L.p. - Net Worth and Insider Trading
Kkr Phorm Investors L.p. Net Worth
The estimated net worth of Kkr Phorm Investors L.p. is at least $119 Million dollars as of 2024-05-25. Kkr Phorm Investors L.p. is the 10% Owner of Transphorm Inc and owns about 24,411,968 shares of Transphorm Inc (TGAN) stock worth over $119 Million. Details can be seen in Kkr Phorm Investors L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kkr Phorm Investors L.p. has not made any transactions after 2023-07-21 and currently still holds the listed stock(s).
Transaction Summary of Kkr Phorm Investors L.p.
Kkr Phorm Investors L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kkr Phorm Investors L.p. owns 1 companies in total, including Transphorm Inc (TGAN) .
Click here to see the complete history of Kkr Phorm Investors L.p.’s form 4 insider trades.
Insider Ownership Summary of Kkr Phorm Investors L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TGAN | Transphorm Inc | 2023-07-21 | 10 percent owner |
Kkr Phorm Investors L.p. Latest Holdings Summary
Kkr Phorm Investors L.p. currently owns a total of 1 stock. Kkr Phorm Investors L.p. owns 24,411,968 shares of Transphorm Inc (TGAN) as of July 21, 2023, with a value of $119 Million.
Latest Holdings of Kkr Phorm Investors L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TGAN | Transphorm Inc | 2023-07-21 | 24,411,968 | 4.89 | 119,374,524 |
Holding Weightings of Kkr Phorm Investors L.p.
Kkr Phorm Investors L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Kkr Phorm Investors L.p. has made a total of 1 transactions in Transphorm Inc (TGAN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Transphorm Inc is the acquisition of 1,735,988 shares on July 21, 2023, which cost Kkr Phorm Investors L.p. around $6 Million.
Insider Trading History of Kkr Phorm Investors L.p.
- 1
Kkr Phorm Investors L.p. Trading Performance
GuruFocus tracks the stock performance after each of Kkr Phorm Investors L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kkr Phorm Investors L.p. is -22.71%. GuruFocus also compares Kkr Phorm Investors L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Kkr Phorm Investors L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kkr Phorm Investors L.p.'s insider trading performs compared to the benchmark.
Performance of Kkr Phorm Investors L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.94 |  | | | | |
| Relative Return to S&P 500(%) | -12.93 | | | | | |
Kkr Phorm Investors L.p. Ownership Network
Kkr Phorm Investors L.p. Owned Company Details
What does Transphorm Inc do?
Who are the key executives at Transphorm Inc?
Kkr Phorm Investors L.p. is the 10 percent owner of Transphorm Inc. Other key executives at Transphorm Inc include Chief Operating Officer Primit Parikh , director & Chief Executive Officer Mario Rivas , and director & Chief Technology Officer Umesh Mishra .
Transphorm Inc (TGAN) Insider Trades Summary
Over the past 18 months, Kkr Phorm Investors L.p. made 1 insider transaction in Transphorm Inc (TGAN) with a net purchase of 1,735,988. Other recent insider transactions involving Transphorm Inc (TGAN) include a net sale of 14,352 shares made by Kelly Smales , a net sale of 13,179 shares made by Katharina G. Mcfarland , and a net sale of 9,500 shares made by Primit Parikh .
In summary, during the past 3 months, insiders sold 16,073 shares of Transphorm Inc (TGAN) in total and bought 0 shares, with a net sale of 16,073 shares. During the past 18 months, 37,031 shares of Transphorm Inc (TGAN) were sold and 1,735,988 shares were bought by its insiders, resulting in a net purchase of 1,698,957 shares.
Transphorm Inc (TGAN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Transphorm Inc Insider Transactions
Kkr Phorm Investors L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Kkr Phorm Investors L.p.. You might contact Kkr Phorm Investors L.p. via mailing address: C/o Kohlberg Kravis Roberts & Co. L.p., 30 Hudson Yards, New York Ny 10001.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
